$1.94
0.063.19%
At close: -
$1.92
-0.02-1.03%
After Hours: 5:44 PM EDT
Comments
Loading...
Virax Biolabs Group (VRAX) Forecast
NewsEarningsVirax Biolabs Group (VRAX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestVirax Biolabs Group (NASDAQ:VRAX) Stock Quotes, Forecast and News Summary
Virax Biolabs Group Stock (NASDAQ: VRAX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Virax Biolabs Group (VRAX) stock?
You can purchase shares of Virax Biolabs Group (NASDAQ:VRAX) through any online brokerage.
Who are Virax Biolabs Group (VRAX) competitors?
Other companies in Virax Biolabs Group’s space includes: Akso Health (NASDAQ:AHG), McKesson (NYSE:MCK), Henry Schein (NASDAQ:HSIC), Patterson Cos (NASDAQ:PDCO) and Cencora (NYSE:COR).
What is the forecast, or price target, for Virax Biolabs Group (VRAX) stock?
There is no analysis for Virax Biolabs Group to provide a consensus price target.
What is the current price for Virax Biolabs Group (VRAX)?
The stock price for Virax Biolabs Group (NASDAQ: VRAX) is $1.92 last updated November 21, 2024 at 5:44 PM EST.
Does Virax Biolabs Group (VRAX) pay a dividend?
There are no upcoming dividends for Virax Biolabs Group.
When is Virax Biolabs Group (NASDAQ:VRAX) reporting earnings?
Virax Biolabs Group’s Q2 earnings are confirmed for Wednesday, February 5, 2025.
Is Virax Biolabs Group (VRAX) going to split?
There is no upcoming split for Virax Biolabs Group.
What sector and industry does Virax Biolabs Group (VRAX) operate in?
Virax Biolabs Group is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.